These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Collagenase 3 production by human osteoarthritic chondrocytes in response to growth factors and cytokines is a function of the physiologic state of the cells. Tardif G, Pelletier JP, Dupuis M, Geng C, Cloutier JM, Martel-Pelletier J. Arthritis Rheum; 1999 Jun; 42(6):1147-58. PubMed ID: 10366107 [Abstract] [Full Text] [Related]
6. The role of cytokines in osteoarthritis pathophysiology. Fernandes JC, Martel-Pelletier J, Pelletier JP. Biorheology; 2002 Oct; 39(1-2):237-46. PubMed ID: 12082286 [Abstract] [Full Text] [Related]
7. Increased type II collagen degradation and very early focal cartilage degeneration is associated with upregulation of chondrocyte differentiation related genes in early human articular cartilage lesions. Tchetina EV, Squires G, Poole AR. J Rheumatol; 2005 May; 32(5):876-86. PubMed ID: 15868625 [Abstract] [Full Text] [Related]
8. Collagenase-1 and collagenase-3 synthesis in normal and early experimental osteoarthritic canine cartilage: an immunohistochemical study. Fernandes JC, Martel-Pelletier J, Lascau-Coman V, Moldovan F, Jovanovic D, Raynauld JP, Pelletier JP. J Rheumatol; 1998 Aug; 25(8):1585-94. PubMed ID: 9712105 [Abstract] [Full Text] [Related]
9. Interleukin 17 (IL-17) induces collagenase-3 production in human osteoarthritic chondrocytes via AP-1 dependent activation: differential activation of AP-1 members by IL-17 and IL-1beta. Benderdour M, Tardif G, Pelletier JP, Di Battista JA, Reboul P, Ranger P, Martel-Pelletier J. J Rheumatol; 2002 Jun; 29(6):1262-72. PubMed ID: 12064845 [Abstract] [Full Text] [Related]
12. Differential patterns of response to doxycycline and transforming growth factor beta1 in the down-regulation of collagenases in osteoarthritic and normal human chondrocytes. Shlopov BV, Smith GN, Cole AA, Hasty KA. Arthritis Rheum; 1999 Apr; 42(4):719-27. PubMed ID: 10211886 [Abstract] [Full Text] [Related]
14. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. Mitchell PG, Magna HA, Reeves LM, Lopresti-Morrow LL, Yocum SA, Rosner PJ, Geoghegan KF, Hambor JE. J Clin Invest; 1996 Feb 01; 97(3):761-8. PubMed ID: 8609233 [Abstract] [Full Text] [Related]
15. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1). Dahlberg L, Billinghurst RC, Manner P, Nelson F, Webb G, Ionescu M, Reiner A, Tanzer M, Zukor D, Chen J, van Wart HE, Poole AR. Arthritis Rheum; 2000 Mar 01; 43(3):673-82. PubMed ID: 10728762 [Abstract] [Full Text] [Related]
18. Galectin-3 surface expression on human adult chondrocytes: a potential substrate for collagenase-3. Guévremont M, Martel-Pelletier J, Boileau C, Liu FT, Richard M, Fernandes JC, Pelletier JP, Reboul P. Ann Rheum Dis; 2004 Jun 01; 63(6):636-43. PubMed ID: 15140769 [Abstract] [Full Text] [Related]
19. Collagenase 1 and collagenase 3 expression in a guinea pig model of osteoarthritis. Huebner JL, Otterness IG, Freund EM, Caterson B, Kraus VB. Arthritis Rheum; 1998 May 01; 41(5):877-90. PubMed ID: 9588741 [Abstract] [Full Text] [Related]
20. Stimulation of collagenase 3 expression in synovial fibroblasts of patients with rheumatoid arthritis by contact with a three-dimensional collagen matrix or with normal cartilage when coimplanted in NOD/SCID mice. Wernicke D, Schulze-Westhoff C, Bräuer R, Petrow P, Zacher J, Gay S, Gromnica-Ihle E. Arthritis Rheum; 2002 Jan 01; 46(1):64-74. PubMed ID: 11817610 [Abstract] [Full Text] [Related] Page: [Next] [New Search]